Agenus, Inc. (AGEN)
4.085
+0.18
(+4.74%)
USD |
NASDAQ |
Apr 27, 16:00
4.085
0.00 (0.00%)
After-Hours: 16:57
Agenus EPS Diluted (Quarterly) : -0.301 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| The Ensign Group, Inc. | 1.610 |
| Inovio Pharmaceuticals, Inc. | 0.0546 |
| Protalix Biotherapeutics, Inc. | -0.0684 |
| CervoMed, Inc. | -0.874 |
| Allogene Therapeutics, Inc. | -0.1717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.61M |
| Revenue (Quarterly) | 34.20M |
| Total Expenses (Quarterly) | 44.78M |
| Enterprise Value | 474.90M |
| Gross Profit Margin (Quarterly) | 98.25% |
| Profit Margin (Quarterly) | -31.03% |
| Earnings Yield | -9.51% |
| Normalized Earnings Yield | -49.57 |